465 related articles for article (PubMed ID: 19519445)
21. The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.
Rioux KP; Madsen KL; Fedorak RN
Gastroenterol Clin North Am; 2005 Sep; 34(3):465-82, ix. PubMed ID: 16084308
[No Abstract] [Full Text] [Related]
22. Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies.
Shanahan F; Quigley EM
Gastroenterology; 2014 May; 146(6):1554-63. PubMed ID: 24486051
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota and inflammatory bowel disease.
Hammer HF
Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210
[TBL] [Abstract][Full Text] [Related]
24. Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.
Owaga E; Hsieh RH; Mugendi B; Masuku S; Shih CK; Chang JS
Int J Mol Sci; 2015 Sep; 16(9):20841-58. PubMed ID: 26340622
[TBL] [Abstract][Full Text] [Related]
25. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.
Kerman DH; Deshpande AR
Postgrad Med; 2014 Jul; 126(4):7-19. PubMed ID: 25141239
[TBL] [Abstract][Full Text] [Related]
27. [Probiotics and prebiotics for the treatment of inflammatory bowel disease].
Mitsuyama K
Nihon Rinsho; 2005 May; 63(5):850-8. PubMed ID: 15881181
[TBL] [Abstract][Full Text] [Related]
28. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
[TBL] [Abstract][Full Text] [Related]
29. Nutritional Support and Probiotics as a Potential Treatment of IBD.
Tarasiuk A; Eibl G
Curr Drug Targets; 2020; 21(14):1417-1427. PubMed ID: 32364071
[TBL] [Abstract][Full Text] [Related]
30. Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights.
Sinagra E; Tomasello G; Cappello F; Leone A; Cottone M; Bellavia M; Rossi F; Facella T; Damiani P; Zeenny MN; Damiani F; Abruzzo A; Damiano G; Palumbo VD; Cocchi M; Jurjus A; Spinelli G; Lo Monte AI; Raimondo D
J Biol Regul Homeost Agents; 2013; 27(4):919-33. PubMed ID: 24382173
[TBL] [Abstract][Full Text] [Related]
31. Exploring & exploiting our 'other self' - does the microbiota hold the key to the future therapy in Crohn's?
Haag LM; Siegmund B
Best Pract Res Clin Gastroenterol; 2014 Jun; 28(3):399-409. PubMed ID: 24913380
[TBL] [Abstract][Full Text] [Related]
32. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
Latella G; Fiocchi C; Caprili R
J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
[TBL] [Abstract][Full Text] [Related]
33. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
Oka A; Sartor RB
Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
[TBL] [Abstract][Full Text] [Related]
34. Intestinal bacteria and inflammatory bowel disease.
Macfarlane S; Steed H; Macfarlane GT
Crit Rev Clin Lab Sci; 2009; 46(1):25-54. PubMed ID: 19107650
[TBL] [Abstract][Full Text] [Related]
35. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
36. Modification of intestinal flora in the treatment of inflammatory bowel disease.
Kanauchi O; Mitsuyama K; Araki Y; Andoh A
Curr Pharm Des; 2003; 9(4):333-46. PubMed ID: 12570821
[TBL] [Abstract][Full Text] [Related]
37. Intestinal microflora as a therapeutic target in inflammatory bowel disease.
Mitsuyama K; Toyonaga A; Sata M
J Gastroenterol; 2002 Nov; 37 Suppl 14():73-7. PubMed ID: 12572870
[TBL] [Abstract][Full Text] [Related]
38. Preclinical and clinical relevance of probiotics and synbiotics in colorectal carcinogenesis: a systematic review.
Cruz BCS; Sarandy MM; Messias AC; Gonçalves RV; Ferreira CLLF; Peluzio MCG
Nutr Rev; 2020 Aug; 78(8):667-687. PubMed ID: 31917829
[TBL] [Abstract][Full Text] [Related]
39. Current, experimental, and future treatments in inflammatory bowel disease: a clinical review.
Hvas CL; Bendix M; Dige A; Dahlerup JF; Agnholt J
Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):446-460. PubMed ID: 29745777
[TBL] [Abstract][Full Text] [Related]
40. IBD and the gut microbiota--from bench to personalized medicine.
Bellaguarda E; Chang EB
Curr Gastroenterol Rep; 2015 Apr; 17(4):15. PubMed ID: 25762474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
